LY294002 prevents lipopolysaccharide‑induced hepatitis in a murine model by suppressing IκB phosphorylation

Chen,Zhize; Liu,Huimin; Lei,Shaoqin; Zhao,Bo; Xia,Zhongyuan

doi:10.3892/mmr.2015.4574

LY294002 prevents lipopolysaccharide‑induced hepatitis in a murine model by suppressing IκB phosphorylation

Authors:
- Zhize Chen
- Huimin Liu
- Shaoqin Lei
- Bo Zhao
- Zhongyuan Xia
View Affiliations

Affiliations: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: November 19, 2015 https://doi.org/10.3892/mmr.2015.4574
Pages: 811-816

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although fulminant hepatitis represents a ubiquitous human health problem, there is a lack of effective therapeutic strategies that have few side‑effects and the precise mechanisms underlying fulminant hepatitis are not fully understood. Phosphoinositide 3‑kinase (PI3K) is a pivotal kinase known to regulate inflammatory responses in hepatic diseases. Although previous research indicates that PI3K is involved in cardiac diseases, including myocardial infarction, it currently remains unclear whether the inhibition of PI3K is essential for ameliorating the severity of lipopolysaccharide (LPS)‑induced hepatitis. The aim of the present study was to investigate whether pharmacological blockade of PI3K ameliorates the development of LPS‑induced murine acute hepatic injury. A murine model of LPS‑induced acute hepatic injury was used to investigate the therapeutic effect of the pan‑PI3K inhibitor, LY294002 on murine fulminant hepatitis and to investigate potential underlying mechanisms. The current report presents the in vivo role of LY294002 in protecting the mice from fulminant hepatitis. LY294002 was observed to exert significant protective effects on the liver by reducing the activities of alanine aminotransferase and aspartate aminotransferase, as well as by improving the histological architecture of the liver. In LPS‑induced hepatitis, treatment with LY294002 clearly inhibited intrahepatic synthesis of various disease‑relevant proinflammatory cytokines, including tumor necrosis factor‑α, interleukin (IL)‑6, IL‑1β and interferon‑γ. Furthermore, LY294002 was observed to significantly inhibit IκB phosphorylation in LPS‑injured mouse liver samples. Therefore, LY294002 may protect the liver from LPS‑induced injury by inhibition of the IκB‑nuclear factor κ‑light‑chain‑enhancer of activated B cell dependent signaling pathway. Thus, the current report provides evidence that LY294002 exerts potent effects against LPS‑induced hepatic injury, indicating its potential therapeutic value for the treatment of acute hepatitis.

View Figures

View References

1	Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
2	Tiegs G, Hentschel J and Wendel A: A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 90:196–203. 1992. View Article : Google Scholar : PubMed/NCBI
3	Moebius U, Manns M, Hess G, Kober G, Meyer zum Büschenfelde KH and Meuer SC: T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): Oligoclonality of PBC-derived T cell clones. Eur J Immunol. 20:889–896. 1990. View Article : Google Scholar : PubMed/NCBI
4	Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N and Tiegs G: Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol. 157:1671–1683. 2000. View Article : Google Scholar : PubMed/NCBI
5	Gantner F, Leist M, Lohse AW, Germann PG and Tiegs G: Concanavalin A-induced T-cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology. 21:190–198. 1995.PubMed/NCBI
6	Koerber K, Sass G, Kiemer AK, Vollmar AM and Tiegs G: In vivo regulation of inducible NO synthase in immune-mediated liver injury in mice. Hepatology. 36:1061–1069. 2002. View Article : Google Scholar : PubMed/NCBI
7	Duran A, Rodriguez A, Martin P, Serrano M, Flores JM, Leitges M, Diaz-Meco MT and Moscat J: Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis. EMBO J. 23:4595–4605. 2004. View Article : Google Scholar : PubMed/NCBI
8	Siebenlist U, Franzoso G and Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 10:405–455. 1994. View Article : Google Scholar : PubMed/NCBI
9	Baeuerle PA and Baltimore D: NF-kappa B: Ten years after. Cell. 87:13–20. 1996. View Article : Google Scholar : PubMed/NCBI
10	Cimino F, Esposito F, Ammendola R and Russo T: Gene regulation by reactive oxygen species. Curr Top Cell Regul. 35:123–148. 1997. View Article : Google Scholar : PubMed/NCBI
11	Wright FL, Moore EE, Nydam TL, et al: QS406. Hypertonic saline inhibits pro-inflammatory effects of cytokine stimulation on pulmonary epithelium at the common pathway of IKB phosphorylation. J Surg Res. 144:4292008. View Article : Google Scholar
12	Ruckle T, Schwarz MK and Rommel C: PI3Kgamma inhibition: Towards an 'aspirin of the 21st century'? Nat Rev Drug Discov. 5:903–918. 2006. View Article : Google Scholar : PubMed/NCBI
13	Peng XD, Wu XH, Chen LJ, Wang ZL, Hu XH, Song LF, He CM, Luo YF, Chen ZZ, Jin K, et al: Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice. J Pharmacol Exp Ther. 332:46–56. 2010. View Article : Google Scholar
14	Kim HS, Park EJ, Park SW, Kim HJ and Chang KC: A tetrahy-droisoquinoline alkaloid THI-28 reduces LPS-induced HMGB1 and diminishes organ injury in septic mice through p38 and PI3K/Nrf2/HO-1 signals. Int Immunopharmacol. 17:684–692. 2013. View Article : Google Scholar : PubMed/NCBI
15	Stahl M, Schupp J, Jäger B, Schmid M, Zissel G, Müller-Quernheim J and Prasse A: Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. Plos One. 8:e813822013. View Article : Google Scholar : PubMed/NCBI
16	Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, et al: PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages and epithelial cells in colitis-induced cancer. Clin Cancer Res. 19:2342–2354. 2013. View Article : Google Scholar : PubMed/NCBI
17	Seropian IM, Abbate A, Toldo S, Harrington J, Smithson L, Ockaili R, Mezzaroma E, Damilano F, Hirsch E and Van Tassell BW: Pharmacologic inhibition of phosphoinositide 3-Kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice. J Cardiovasc Pharmacol. 56:651–658. 2010. View Article : Google Scholar : PubMed/NCBI
18	Siragusa M, Katare R, Meloni M, Damilano F, Hirsch E, Emanueli C and Madeddu P: Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res. 106:757–768. 2010. View Article : Google Scholar : PubMed/NCBI
19	Wang ZL, Wu XH, Song LF, Wang YS, Hu XH, Luo YF, Chen ZZ, Ke J, Peng XD, He CM, et al: Phosphoinositide 3-kinase gamma inhibitor ameliorates concanavalin A-induced hepatic injury in mice. Biochem Biophys Res Commun. 386:569–574. 2009. View Article : Google Scholar : PubMed/NCBI
20	Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM and Eriksson U: T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med. 203:2009–2019. 2006. View Article : Google Scholar : PubMed/NCBI
21	Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M and Penninger JM: Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med. 9:1484–1490. 2003. View Article : Google Scholar : PubMed/NCBI
22	Affò S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, Millán C, Coll M, Caviglia JM, Arroyo V, et al: CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut. 63:1782–1792. 2014. View Article : Google Scholar : PubMed/NCBI
23	Bao XQ and Liu GT: Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-Induced liver injury through suppression of nuclear factor-kappaB in mice. Mol Pharmacol. 75:1180–1188. 2009. View Article : Google Scholar : PubMed/NCBI
24	Banan A, Shaikh M, Zhang L, et al: Upregulation of NF-κB, IκBα phosphorylation (IκBα.P), iNOS and cytoskeletal protein oxidation and dysfunction in colonic mucosa of patients with inflammatory bowel disease (IBD). Gastroenterology. 124:A1982003. View Article : Google Scholar
25	Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ and Israël A: Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 93:1231–1240. 1998. View Article : Google Scholar : PubMed/NCBI
26	Xie JH, Yamniuk AP, Borowski V, Kuhn R, Susulic V, Rex-Rabe S, Yang X, Zhou X, Zhang Y, Gillooly K, et al: Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases. J Immunol. 192:4083–4092. 2014. View Article : Google Scholar : PubMed/NCBI
27	Watanabe R, Azuma RW, Suzuki J, Ogawa M, Itai A, Hirata Y, Komuro I and Isobe M: Inhibition of NF-κB activation by a novel IKK inhibitor reduces the severity of experimental autoimmune myocarditis via suppression of T-cell activation. Am J Physiol Heart Circ Physiol. 305:H1761–H1771. 2013. View Article : Google Scholar : PubMed/NCBI
28	Dinarello CA, Simon A and van der Meer JW: Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 11:633–652. 2012. View Article : Google Scholar : PubMed/NCBI
29	Knulst AC, Tibbe GJ, Bril-Bazuin C, Breedland EG, van Oudenarena, Benner R and Savelkoul HF: Cytokine detection and modulation in acute graft vs. host disease in mice. Mediators Inflamm. 3:33–40. 1994. View Article : Google Scholar : PubMed/NCBI
30	Van de Laar L, Buitenhuis M, Wensveen FM, Janssen HL, Coffer PJ and Woltman AM: Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling. J Immunol. 184:6600–6611. 2010. View Article : Google Scholar : PubMed/NCBI
31	Rao J, Qian X, Li G, Pan X, Zhang C, Zhang F, Zhai Y, X and Lu L: ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury. Am J Transplant. 15:76–87. 2015. View Article : Google Scholar
32	Yoo SY, Le TK, Jeong JJ and Kim DH: Poligapolide, a PI3K/Akt inhibitor in immunodeficiency virus type 1 TAT-transduced CHME5 cells, isolated from the rhizome of Polygala tenuifolia. Chem Pharm Bull (Tokyo). 62:467–471. 2014. View Article : Google Scholar
33	Liu SQ, Jiang S, Li C, Zhang B and Li QJ: miR-17–92 cluster targets phosphatase and tensin homology and ikaros family zinc finger 4 to promote TH17-mediated inflammation. J Biol Chem. 289:12446–12456. 2014. View Article : Google Scholar : PubMed/NCBI
34	Goodwin CB, Li XJ, Mali RS, Chan G, Kang M, Liu Z, Vanhaesebroeck B, Neel BG, Loh ML, Lannutti BJ, et al: PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML. Blood. 123:2838–2842. 2014. View Article : Google Scholar : PubMed/NCBI
35	Zhang E, Feng X, Liu F, Zhang P, Liang J and Tang X: Roles of PI3K/Akt and c-jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. Plos One. 9:e1034402014. View Article : Google Scholar
36	Eräsalo H, Laavola M, Hämäläinen M, Leppänen T, Nieminen R and Moilanen E: PI3K Inhibitors LY294002 and IC87114 reduce inflammation in carrageenan-induced paw oedema and down-regulate inflammatory gene expression in activated macrophages. Basic Clin Pharmacol Toxicol. 116:53–61. 2015. View Article : Google Scholar